GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beit Jala Pharmaceutical Co (XPAE:BJP) » Definitions » Change In Receivables

Beit Jala Pharmaceutical Co (XPAE:BJP) Change In Receivables : JOD0.00 Mil (TTM As of . 20)


View and export this data going back to 2015. Start your Free Trial

What is Beit Jala Pharmaceutical Co Change In Receivables?

Beit Jala Pharmaceutical Co's change in receivables for the quarter that ended in . 20 was JOD0.00 Mil. It means Beit Jala Pharmaceutical Co's Accounts Receivable stayed the same from . 20 to . 20 .

Beit Jala Pharmaceutical Co's change in receivables for the fiscal year that ended in . 20 was JOD0.00 Mil. It means Beit Jala Pharmaceutical Co's Accounts Receivable stayed the same from . 20 to . 20 .

Beit Jala Pharmaceutical Co's Accounts Receivable for the quarter that ended in . 20 was JOD0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Beit Jala Pharmaceutical Co's liquidation value for the six months ended in . 20 was JOD0.00 Mil.

Beit Jala Pharmaceutical Co Change In Receivables Historical Data

The historical data trend for Beit Jala Pharmaceutical Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beit Jala Pharmaceutical Co Change In Receivables Chart

Beit Jala Pharmaceutical Co Annual Data
Trend
Change In Receivables

Beit Jala Pharmaceutical Co Semi-Annual Data
Change In Receivables

Beit Jala Pharmaceutical Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Receivables for the trailing twelve months (TTM) ended in . 20 was JOD0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beit Jala Pharmaceutical Co  (XPAE:BJP) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Beit Jala Pharmaceutical Co's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=/*91
=

2. In Ben Graham's calculation of liquidation value, Beit Jala Pharmaceutical Co's accounts receivable are only considered to be worth 75% of book value:

Beit Jala Pharmaceutical Co's liquidation value for the quarter that ended in . 20 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=-+0.75 * +0.5 *
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beit Jala Pharmaceutical Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Beit Jala Pharmaceutical Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Beit Jala Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beit Jala Pharmaceutical Co (XPAE:BJP) » Definitions » Change In Receivables
Comparable Companies
Traded in Other Exchanges
N/A
Address
81, Al-Madares Street, Beit Jala, West Bank, Beit Jala, PSE, 97300
Website
https://www.beitjalapharma.com
Beit Jala Pharmaceutical Co is a manufacturer of pharmaceutical products. The company's products include tablets, capsules, powders, syrups, solutions, oral drops, creams, gels, lotions, medicated shampoo, suppositories and ointments.

Beit Jala Pharmaceutical Co Headlines

No Headlines